Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

22nd Century Group Inc (XXII)

22nd Century Group Inc (XXII)
1.1000 +0.0500 (+4.76%) 04/07/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 1.0890 -0.0110 (-1.00%) 19:23 ET
Quote Overview for Mon, Apr 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.9700
Day High
1.1000
Open 1.0400
Previous Close 1.0500 1.0500
Volume 117,100 117,100
Avg Vol 65,150 65,150
Stochastic %K 9.13% 9.13%
Weighted Alpha -98.26 -98.26
5-Day Change -0.3400 (-23.61%) -0.3400 (-23.61%)
52-Week Range 0.9700 - 369.2250 0.9700 - 369.2250
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,488
  • Shares Outstanding, K 2,370
  • Annual Sales, $ 24,380 K
  • Annual Income, $ -15,160 K
  • EBIT $ -14 M
  • EBITDA $ -13 M
  • 60-Month Beta 2.03
  • Price/Sales 0.11
  • Price/Cash Flow N/A
  • Price/Book 0.50

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 99.75%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.87
  • Number of Estimates 1
  • High Estimate -0.87
  • Low Estimate -0.87
  • Prior Year -232.43
  • Growth Rate Est. (year over year) +99.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9700 +13.40%
on 04/07/25
Period Open: 2.0800
2.0772 -47.04%
on 03/12/25
-0.9800 (-47.12%)
since 03/07/25
3-Month
0.9700 +13.40%
on 04/07/25
Period Open: 5.7500
12.4900 -91.19%
on 01/13/25
-4.6500 (-80.87%)
since 01/07/25
52-Week
0.9700 +13.40%
on 04/07/25
Period Open: 480.6000
369.2250 -99.70%
on 04/08/24
-479.5000 (-99.77%)
since 04/05/24

Most Recent Stories

More News
22nd Century Group Reports Fourth Quarter and Full Year 2024 Financial Results 

XXII : 1.1000 (+4.76%)
22nd Century Group to Announce Fourth Quarter and Full Year 2024 Results on March 20, 2025

XXII : 1.1000 (+4.76%)
22nd Century Announces First Partner VLN Agreement, New VLN Availability with Smoker Friendly

XXII : 1.1000 (+4.76%)
Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII)

Sheridan, Wyoming--(Newsfile Corp. - February 19, 2025) - Emerging Growth Research is pleased to announce the release of its new initiation report on the 22nd Century Group, Inc. (NASDAQ: XXII). The Company...

XXII : 1.1000 (+4.76%)
22nd Century to Present at the Emerging Growth Conference on February 19, 2025

XXII : 1.1000 (+4.76%)
22nd Century Regains Full Compliance with Nasdaq Continued Listing Standards

XXII : 1.1000 (+4.76%)
FDA Publishes Proposed New Tobacco Product Standard for Nicotine Yield, Citing VLN from 22nd Century as the Only Combustible Cigarette That Complies with the New Standard

XXII : 1.1000 (+4.76%)
Washington Post Story Featuring 22nd Century VLN Products Highlights Proposed FDA Reduced Nicotine Content Policy Could Initially Benefit An Estimated 13 Million Smokers

XXII : 1.1000 (+4.76%)
22nd Century Group Stock Rises On Proposed FDA Mandate On Nicotine Content: Retail's Extremely Bullish

Sentiment on Stocktwits was 'extremely bullish' compared to 'neutral'

VXF : 154.14 (-0.78%)
XXII : 1.1000 (+4.76%)
22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes

XXII : 1.1000 (+4.76%)

Business Summary

22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products...

See More

Key Turning Points

3rd Resistance Point 1.2733
2nd Resistance Point 1.1867
1st Resistance Point 1.1433
Last Price 1.1000
1st Support Level 1.0133
2nd Support Level 0.9267
3rd Support Level 0.8833

See More

52-Week High 369.2250
Fibonacci 61.8% 228.5516
Fibonacci 50% 185.0975
Fibonacci 38.2% 141.6434
Last Price 1.1000
52-Week Low 0.9700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades